Neurological Biomarkers Market Demand and Growth Analysis 2023

1
Neurological Biomarkers Market (2023-29)
2
Market Overview
The global neurological biomarkers market size
was valued at USD 7 billion in 2022 and is poised
to grow at a significant CAGR of 12.9 during the
forecast period 2023-29. The neurological
biomarkers market research report also provides
opportunities for business owners to exploit
through the use of relevant approaches. The
studys prospects assist stakeholders and report
purchasers in properly planning their investments
and augmenting their profits. The report
provides a quantitative analysis of the market
segments, trends, estimations, and dynamics of
the neurological biomarkers market analysis from
2023 to 2029 to identify the prevailing market
opportunities. In addition, the report discusses
the implications of COVID-19, including the
industry's initial response and strategies for
ensuring business continuity in the coming
years. View Detailed Report Description
3
Market Segments
The neurological biomarkers market has been
fragmented based on 1) By Type Metabolomic
Biomarkers, Proteomic Biomarkers, Genomic
Biomarkers, Imaging Biomarkers, Others 2) By
Application Alzheimer's, Autism Spectrum
Disorder and Parkinson's, Multiple Sclerosis 3)
By End-use Clinical Diagnostic Centers, Hospital
Laboratories, Research Organizations,
Others Request Sample Report
4
Key Players
Some of the major key players in the neurological
biomarkers market are Abbott Laboratories Myriad
Rbm, Inc Athena Diagnostics Immunarray Pvt.
Ltd Acumen Pharmaceuticals Inc Banyan Biomarkers
Inc Request Sample Report
5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB
Colony, Hyderabad 500072 Email sales_at_precisionb
usinessinsights.com Toll-Free 1-866-598-1553